POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No85/2017
Date of issue:2017-09-19
Short name of the issuer
SOPHARMA AD
Subject
Notification for acquisition of own shares
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
SOPHARMA AD hereby informs that from 15 September 2017 up to and including 18 September 2017 the Company bought 10 600 own shares representing 0.0079% of the share capital of the Company, at a total value of 44 878.01 BGN on the Bulgarian Stock Exchange, the average price per share was 4.23 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 329 317, representing 3.95 % of the share capital of the Company.
Annexes
FileDescription
Current report 85 buy back 18092017.docNotification for acquisition of own shares
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2017-09-19Ognian DonevExecutive director
Current report 85 buy back 18092017.doc